Your browser doesn't support javascript.
loading
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.
Renneville, Aline; Gasser, Jessica A; Grinshpun, Daniel E; Jean Beltran, Pierre M; Udeshi, Namrata D; Matyskiela, Mary E; Clayton, Thomas; McConkey, Marie; Viswanathan, Kaushik; Tepper, Alexander; Guirguis, Andrew A; Sellar, Rob S; Cotteret, Sophie; Marzac, Christophe; Saada, Véronique; De Botton, Stéphane; Kiladjian, Jean-Jacques; Cayuela, Jean-Michel; Rolfe, Mark; Chamberlain, Philip P; Carr, Steven A; Ebert, Benjamin L.
Afiliação
  • Renneville A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Gasser JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Grinshpun DE; INSERM U1287, Gustave Roussy Cancer Campus, Villejuif, France.
  • Jean Beltran PM; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Udeshi ND; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Matyskiela ME; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Clayton T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • McConkey M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Viswanathan K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Tepper A; Celgene/Bristol-Myers Squibb Corporation, San Diego, California.
  • Guirguis AA; Celgene/Bristol-Myers Squibb Corporation, San Diego, California.
  • Sellar RS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cotteret S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Marzac C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Saada V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • De Botton S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Kiladjian JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cayuela JM; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Rolfe M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Chamberlain PP; Department of Haematology, UCL Cancer Institute, London, United Kingdom.
  • Carr SA; Département de Biologie et Pathologie, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ebert BL; Département de Biologie et Pathologie, Gustave Roussy Cancer Campus, Villejuif, France.
Blood Cancer Discov ; 2(3): 250-265, 2021 05.
Article em En | MEDLINE | ID: mdl-34027417
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Neoplasias Hematológicas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Neoplasias Hematológicas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article